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INTRODUCTION 
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Lower urinary tract symptoms (LUTS) and sexual dysfunction are common in the 
aging male. The association between these two conditions are not yet defined (1,2) . 
Lately studies using International Prostate Symptom Score, have shown a 
prevalence rate of Erectile dysfunction (ED) to be >50% in men aged 50 years and 
above (1). 
Traditionally, less attention has been paid to the association between sexual 
dysfunction and lower urinary tract symptoms. The exact mechanisms via which 
lower urinary tract symptoms appears to affect sexual function in aging population is 
still being elusive, 
 
With the growing interest in men`s health, and increased problem of sexual 
dysfunction this has attracted some attention. LUTS is  meticulously evaluated  and 
treated by  all,  whereas  urologists often look into  sexual dysfunction in these men.  
Presently immense attention has been focused on the same at the international level  
but there is a paucity in the  Indian literature.  
India is a developing country with diverse culture, religion, language and attitude. But 
still faces problems related to unemployment, illiteracy, lack of awareness and 
mortality due to negligence. Though advancement in health field renders an 
accessible amount of opportunities to people in treating them still men in India differs 
a lot from those of men in western countries.  
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The degree of illiteracy, social taboos and ignorance have made them disinterested 
in seeking medical treatment. Men in India also have a great difficulty in approaching 
medical remedies due to their poor socio economic back ground. 
With this in mind we designed a study to evaluate the association  between Lower 
Urinary Tract Symptoms (LUTS) and sexual dysfunction. 
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AIMS AND OBJECTIVES 
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We performed a case control study to look for the association between Lower 
Urinary Tract Symptoms (LUTS) and sexual dysfunction in men above 50 
years at a tertiary care centre.  
 
Primary objective of the study: 
a)  to find the association of Lower urinary tracts symptoms (LUTS) with 
Sexual dysfunction 
 
Secondary objectives were: 
a) To find the association of severity of LUTS with sexual dysfunction.   
b) Association of co-morbidities with sexual dysfunction 
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Review of Literature 
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The 1990s has drawn much attention to gender -based medicine. Extensive 
research have yielded important findings about health and disease in men. 
However this knowledge hasn`t borne the expected benefits. Men are less 
conscious than women to seek medical care,. Nearly fifty percent of males are 
likely to  pursue health visits or screening tests  when compared to their 
counterpart (3).  Recent data shows nearly 68.6% of men above 20 years of age 
are obese. As per the data provided by Kung HC et al life expectancy of male  
trails that of females by 5.3 year (4). 
The concept of Men‘s Health is in its nascent state in comparison to women‘s. 
Men‘s Health is considered by many clinicians to a field concerned with sexual 
function and prostate. This has recently become a pursued subject in and around 
world.  Millions of dollars are being spent on evaluation of prostate related issues, 
better urinary flow and improved erections. On the contrary only a negligible  
amount is being directed to overall improvement of health (5). 
Men are more likely to be persuaded to visit their physicians for events such as 
sports related injuries, alopecia or erectile dysfunction. This presentation to 
clinician can give an opportunity for a more complete evaluation. In an article 
published in December, 2005, By Thompson and colleagues (6)  confirmed  that 
erectile dysfunction  is a primary event which turns out to be   a major risk factor 
for cardiovascular   accidents. 
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Lower urinary tract  symptoms (LUTS) – 
“Bladder is an unreliable witness”  - Bates (1970) 
Paul Abrams is the one who coined the term lower urinary tract symptoms. It 
described symptoms such as prostatism and clinical benign prostatic hyperplasia. 
This showed that symptoms were due to prostatic pathology and often treated 
without substantial evidence of underlying cause (7). There were enough evidence 
by this time that similar symptoms were seen in elderly females and they could not 
have been attributed to prostatic pathology. There were no  evidence that would cite 
benign prostatic enlargement as the cause of LUTS. Associations could not be 
shown between either individual symptoms or group of symptoms. The only 
exception was the association of day time frequency, urgency and urge incontinence 
with overactivity of the dertrusor based on urodynamic study. LUTS described 
symptoms without describing etiology, as symptoms are neither age, sex nor organ 
specific (7). For these reasons, the terms ‗voiding‘ and ‗storage‘ were replaced by 
irritative and obstructive symptoms. Voiding symptoms can also be due to detrusor 
underactivity rather than bladder outlet obstruction alone. When evaluating  an 
elderly gentleman one can classify  LUTS  according to standardized questionnaire 
depending on its symptoms ranging from   mild, moderate and severe lower urinary 
tracts symptoms. LUTS  is a combination of  symptoms that is attributed to disease  
that involves lower urinary tract.  
 
The symptoms of lower urinary tract symptoms can be classified as: storage, voiding 
and post micturition symptoms.  
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1) Storage symptoms are those that are experienced by an individual during the 
storage phase of the bladder and they manifest as increased  frequency 
during the day, urgency with occasional urinary incontinence and nocturia. 
 
2)  Voiding urinary symptoms are experienced during the voiding phase of 
micturition. It includes: decreased in the   flow of urinary stream, splitting or 
spraying of the urinary stream, intermittency, hesitancy, straining to void and 
terminal dribbling of urine. 
 
3) Post micturition symptoms   comprises sensation of incomplete voiding and 
post voidal dribbling.  
 
LUTS  have a negative impact on    many patients. The level of discomfort vary 
significantly among individual with the  same level of symptom  and severity. The 
lower urinary tract symptoms has a variable impact on the quality of life and is 
independent of pysiological factors. The individual‘s insight  on  the severity of the 
condition and its interference  in performing his  daily activities may cause  
embarrassment. This  is the principal consideration in one`s  decision to seek  
medical treatment. 
Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging 
men.  It can be associated with distressing lower urinary tract symptoms (LUTS). 
Nearly fifty percent of all men who is   diagnosed of BPH have moderate to severe 
degree of LUTS. The primary complaints of the patient is  bothersome lower urinary 
tract symptoms which is manifested as decreased flow of urine, increased urinary  
frequency, urgency, nocturia, intermittency and sense of incomplete voiding. The 
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association between BPH and LUTS is complex. Several other conditions in the 
lower urinary tract and elsewhere may be causative of the symptom complex. Not 
every patients with lower urinary tract symptoms have prostatic enlargement. 
 
 
 
Figure 1: Diagram interpreting the relationship between BPE, BPH, LUTS and BOO 
(8). 
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Analytical Epidemiologic Studies of BPH: 
Socioeconomic Factors 
There is a difference of opinion regarding the effect of socioeconomic factors  on 
BPH. Some have opined higher rates of prostate related surgeries in the affluent 
class on the other hand others have opined that the BPH related surgery is more in 
the lower socio economic group. The BACH study have shown that the inability to 
pay for their health related affairs were the ones with more severe symptoms.  (9). 
Alcohol and Liver Cirrhosis 
Alcohol consumption is likely to  inhibit the production of  serum testosterone 
production and its clearance. Inspite of  this presumed reason for decreased 
incidence of benign prostatic hyperplasia, studies have shown the opposite result.  
scrutiny of the PCPT (Prostate Cancer Prevention Trial) demonstrated a protective 
effect (10)  between    BPH and alcohol intake. 
Essential Hypertension: The sympathetic nervous system through the adrenergic 
receptors and fibres appears to play a sentinel part in the development of the 
symptoms of BPH and hypertension. The incidence of LUTS and hypertension is 
reported to advance with advancing age.  To prove  an underlying relationship 
between these two conditions is often difficult. Often the hyperactivity of the 
autonomic nervous system has been drawn in as a cause for the development of 
both erectile dysfunction and lower urinary tract systems. However a definite clinical 
data is  missing (11). 
Smoking: Smoking seems to enhance the level of  both estrogens and testosterone 
due  to the effect of  nicotine . This seems to have an positive impact on the 
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development of benign prostatic hyperplasia. Studies have shown a biphasic 
relationship between smokers and development of BPH. Moderate smokers were at 
lesser risk to develop moderate to severe symptoms. On the contrary chain smokers 
and non smokers were at the same risk for the development of the symptoms. The 
Olmsted County study have showed that smoking causes decreased flow of urine 
and development of moderate and severe symptoms. But it didn‘t  show any 
association  with increase in the size of prostate or a rising  serum PSA (12). 
 
Physical Activity and the Metabolic Syndrome: There is no substantial evidence 
that dietary factor plays a part in the development of benign prostatic hyperplasia 
and lower urinary tract symptoms. The associations between lower urinary tract 
symptoms, benign prostatic hyperplasia, body mass index and the metabolic 
syndrome have lately gained immense interest (8). Metabolic syndrome is a 
condition which compromises dyslipidemia, glucose intolerance, obesity and 
hypertension that causes an increase in the risk for development of cardiovascular 
disease. This occurs primarily from risk factors that can be modified such as lack of 
physical activity and dietary habits. It is more pronounced in the Westernized 
societies. 
 Presently evidence suggests a positive association between obesity, physical 
inactivity, body mass index and the development of both Lower urinary tract 
symptoms and benign prostatic hyperplasia. Regular physical activity have been  
shown to have a protective role on the development of metabolic syndrome (13). 
 
Sexual dysfunction: Sexual dysfunction is defined as the failure to enjoy sexual 
intercourse completely. Sexual dysfunction takes variant forms in males and 
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females. Man may have a sexual problem if he ejaculates prior to his or  his 
partner`s desires, failure experiences delayed ejaculation, is unable to have an 
erection sufficient for penetration and pleasurable intercourse, painful  intercourse, 
lacks or loses sexual desire.   
The International Index of Erectile Function (IIEF) was designed to be available in 
various languages. It was devised to attend to the needs of various worldwide 
agencies. It has been accepted as the ‗gold standard‘ to measure the outcome of 
treatment or clinical trials in erectile dysfunction. IIEF has been in use regardless of 
the type of treatment involved or population being evaluated. It was recommended 
by the first International Consultation on Erectile Dysfunction (14), as a tool to 
measure the outcome of clinical trials for erectile dysfunction. This was, sponsored 
by the World Health Organization. Ever since its inception in 1997 it has been used 
to conduct more than 50 trials using various treatment agents different study group. 
International Prostate Symptom Score (IPSS): The International Prostate 
Symptom Score contains  eight question (seven symptom related and one QOL, 
quality of life question) screening tool. This is used to diagnose, identify the 
symptoms and suggest management. This tool was introduced in 1992 by the 
American Urological Association. At that time it lacked the 8th question (QOL, quality 
of life). This was known by the name-AUA -7 ( American Urological Association 
symptom score).  
 International Prostate Symptom Score has played  a fundamental role in the clinical 
study of  lower urinary tract symptoms and benign prostatic hyperplasia.(15) 
The IPSS consists of a total score varying from zero to thirty-five points. Those with 
score of 0 to 7 are grouped into mildly symptomatic group. Those scoring 8 to 19 
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classified into moderately symptomatic. Finally those scoring more than 20 are 
categorised as severely symptomatic. This has become an integral part of not only 
epidemiologic studies but also treatment studies. The accessibility of this scale in 
validated translations in various languages allows comparison across various cultural 
group. 
 
Relevant anatomy and physiology of lower urinary tract in males: 
Bladder muscular and mucosal arrangement: 
The urinary bladder is divided structurally into 3 parts: supratrigonal, trigonal and 
bladder neck. The supra trigonal part of bladder is mainly composed mainly of 
randomly arranged fibres of the detrusor with overlying urothelium. The supratrigonal 
region is a seven cell layers thick with a loose underlying lamina propria below it 
which allows for bladder distension on filling. 
The trigonal region is bounded by the two ureteric orifice and internal urethral 
meatus. The epithelium is only 3 cell layer thick in this region. It has a dense and 
thick lamina propria, which is attached tightly to underlying muscle. The muscles in 
trigonal area have well defined layers. The inner most layer is continuation of the 
inner ureteric muscles forming superficial trigonal muscle. The deep trigonal muscle 
layer is formed by the continuation of Waldayer`s sheath. The outermost layer is 
continuation of detrusor muscle and is arranged in inner circular and outer 
longitudinal layers. 
Bladder neck in male involves continuation of muscles from the trigonal region  (16) 
The superficial trigonal muscle layer continues till the verumontanum. Deep trigonal 
Page | 22 
 
muscle ends at the bladder neck. Continuation of outer circular muscle from trigonal 
region along with the fibromuscular part of prostate, forms ring like structure in the 
bladder neck region. The longitudinal detrusor muscle fibers, which are posteriorly 
placed, continue at bladder neck in ring like fashion and form an effective bladder 
neck sphincter.   
Bladder Circulation:  
Arterial supply: Superior and inferior vesical arteries arise from anterior branch of 
internal iliac artery and reach bladder via lateral and posterior pedicle respectively. 
There can be some direct branches from the internal iliac artery apart from the 
named ones.  
Venous drainage: Small veins draining bladder form vesical plexus, which also 
receives blood from the dorsal penile vein in males. This plexus drains into the 
internal iliac vein.  
Lymphatic drainage is mainly to external iliac group of nodes via perivesical 
channels and nodes. Anterior and lateral part may get drained directly to obturator 
and internal iliac group of nodes. The bladder base and trigonal region drains into 
the internal iliac and common iliac group of nodes. 
Bladder innervation:  
Bladder is supplied by autonomic nerves, both sympathetic and parasympathetic. 
Efferent fibers reach bladder via lateral and posterior pedicles through pelvic plexus. 
Sympathetic supply has its origin in thoracolumber segment and reaches pelvic 
plexus by the superior hypogastric plexus and nerves. Parasympathetic efferent 
originate in sacral segment and reach bladder via pelvic plexus. Parasympathetic 
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efferent is mainly responsible for detrusor contractions. The bladder neck area has 
adrenergic innervation that is responsible for bladder neck sphincter contraction. The 
sympathetic innervation to the detrusor though sparse is thought to be responsible 
for detrusor muscle relaxation. The afferent fibers travel in both sympathetic and 
parasympathetic fibers. 
 
Figure 2: Bladder Neuronal innervations 
 
Prostate  
Anatomical considerations 
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Prostate is an ovoid structure which extends from bladder base to the membranous 
urethra. Prostate is bounded by a capsule which is more prominent posteriorly and 
laterally. It is composed of elastin, collagen and smooth muscle fibers. Denonvillers‘ 
fascia is located posterior to the prostate. There are smooth muscle fibers which 
transverse from the prostatic capsule to the Denonvillers fascia, and an areolar 
tissue layer is placed between the rectum and Denonvillers. Anteriorly and laterally it 
is covered by visceral endopelvic fascia which also covers the periprostatic venous 
plexus. Laterally pubococcygeal part of levator ani with its parietal endopelvic fascia 
surrounds it. The pelvic fascia is thickened at place where prostatic visceral and 
parietal endopelvic fascia covering levator ani meets forming arcus tendineus fascia 
pelvis. The cavernosal nerves maintain a postero-lateral relationship to prostate and 
are invested by the parietal pelvic fascia. Apex of prostate continues with the striated 
sphincter. Microscopically some prostatic glands can be seen invading the striated 
muscle of the sphincter. Prostatic urethra runs through it. Urethra is lined by 
transitional epithelium and is closer to the anterior surface. Prostatic urethra 
angulates anteriorly at midpoint. The angulation is approximately 35 degrees, can 
vary form 0-90 degrees. The proximal part of prostate before angulation (preprostatic 
urethra) has preprostatic sphincter (bladder neck) in males and periurethral glands 
drain into it. Prostatic urethra receives glandular secretions from peripheral part of 
prostate, ejaculatory ducts and utricle at verumontanum. Transitional zone glands 
drain at the junction of preprostatic and prostatic urethra. The glands of central zone 
drain into the ejaculatory ducts and are probably derived embryologically from 
urogenital sinus. These two parts of prostatic urethra differ in function also (17). 
Anterior fibromuscular stroma forms the anterior portion of prostate. It is devoid of 
glandular structures and extends from bladder neck to the striated sphincter.  
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Prostatic circulation:  
Arterial supply of prostate: Mainly by the inferior vesical artery. Inferior vesical artery 
divides into urethral branch and capsular branch. Urethral branches penetrate the 
prostate at its base and run parallel to the prostatic urethra caudally. Most of the 
branches lie form 1-5 o‘ clock position and 7-11 o‘ clock position. These urethra 
branches mainly supply transitional zone and periurethral zone glands. Capsular 
branches also run posterolaterally with cavernosal nerves and pierce the capsule to 
run perpendicularly to supply the peripheral zone.  
Venous drainage: Periprostatic venous plexus is responsible for venous drainage of 
the prostate. The dorsal vein and perivesical venous plexus is in continuity with 
periprostatic venous plexus and they drain into the internal iliac vein.  
 Lymphatic drainage –into internal iliac nodes and the obturator nodes mainly. Some 
drainage occurs into the presacral group and external iliac group of nodes. 
Prostatic innervation: 
Sympathetic and parasymphathetic nerve supply of prostate arise form thoraco-
dorsal and sacral nerve roots respectively. Sympathetic nerves are responsible for 
the contraction of smooth muscles of prostate including the bladder neck and the 
parasympathetic nerves stimulate glandular secretions. Afferent nerves also travel 
along them and can be blocked at the base of prostate during the prostatic biopsy. 
 
Membranous urethra: 
Anatomy 
Page | 26 
 
Membranous urethra spans from the apex of prostate to the bulbar urethra and is on 
an average 2.5 cm long. It is surrounded by a striated sphincter which is omega 
shaped. It is thinnest posteriorly as most of its fibers splay laterally. Most of striated 
sphincter is composed of type 1 muscle fibers, which are of the slow twitch type and 
can contract for long time. Somatic supply to the sphincter is via pudendal nerve and 
some branches from the pelvic plexus travel above the levator ani to reach sphincter. 
Autonomic supply is probably via cavernosal nerves, however their significance in 
maintaining continence is not known. Not much is known about the afferent nerve 
supply. The mechanisms necessary in maintaining continence in males include, 
mucosal folds which coapt during contraction to form a watertight seal, the 
submucosal tissue and the connective tissue including the puboprostatic ligaments 
and suspensory ligaments, smooth muscles at bladder neck and smooth and 
skeletal muscles of striated sphincter and pubococcygeal muscle of levator ani. 
Physiology of Lower urinary tracts 
The lower urinary tract functions can be summarized as: reservoir of urine at low 
pressure,  maintenance of continence and voluntary periodic complete expulsion of 
urine at low pressures. These occurs in two phases: the storage phase and the 
voiding phase. 
Storage phase:  
Bladder should stores urine at low pressure during the storage phase with 
appropriate sensations without overactivity. The bladder matrix is mainly composed 
of elastin and collagen. Elasticity and viscoelasticity are partly responsible for normal 
bladder compliance. Various neuronal mechanisms also plays a role in maintaining 
low pressure storage during the filling phase. Sympathetic nerves  cause contraction 
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of bladder neck by stimulating alpha 1 receptors predominantly present at bladder 
neck thus maintaining continence. Excitation of Beta 3 receptors present on detrusor 
smooth muscles is proposed to relax the bladder musculature during filling phase. 
Increased afferent activity in the pudendal nerve during the storage phase may 
inhibit the effector neurons which supply the detrusor muscle. It has been proposed 
that urothelium release of some inhibitory mediators which causes relaxation of 
detrusor smooth muscle. 
Voiding Phase: 
Voiding is result of coordinated neural activity. It is initiated at cortex and coordinated 
at micturition centre located at pons in the midbrain. Voiding is initiated when the 
sensation of bladder filling reaches the threshold to initiate a micturition reflex. The  
inhibited is maintained by the centre at midbrain and sacral parasympathetic outflow 
via the pelvic nerve. Parasympathetic outflow causes coordinated detrusor smooth 
muscle contraction that rsults in bladder emptying. Funneling of bladder neck is seen 
when vesical pressure increases above the proximal urethral pressure. The 
contraction of longitudinal smooth muscle during voiding causes shortening and 
widening of the proximal urethra.  
Sensations of filling and distension normally occur during filling phase and are 
responsible for initiating micturition, whereas sensation of urgency and pain are 
pathological. Most of this afferent activity travels in pelvic nerves and enter spinal 
cord at sacral level (18). 
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Figure 3:  Neural activity during voiding and storage phases 
 
 LUTS and sexual dysfunction: The association between lower urinary tract 
symptoms  and erectile dysfunction has come into limelight recently because both 
diseases are not only highly prevalent but also occur in the same age  group in 
males. This association bears significantly to the overall quality of life. The Cologne 
study of Germany performed a survey of 4489 men in the age between  30–80 
years. A self-administered questionnaire was used and found the prevalence of 
lower urinary tract symptoms was found to be  around  72% in men with erectile 
dysfunction, whereas it was  38% in men without erectile dysfunction3. They further 
found an increase in the prevalence of erectile dysfunction in older age groups. This 
was noticed irrespective of the presence of LUTS in the above mentioned group. The 
presence of erectile dysfunction was also significantly associated amongst 
individuals who had undergone a pelvic surgery ,and  in those who had co 
morbidities like hypertension and  diabetis mellitus.  
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The Cross National Study was a community based study which was undertaken  to 
find the prevalence of erectile dysfunction  in Malaysia, Japan, Italy and Brazil (19). 
They interviewed  2400 men (~ 600 per country). This interview was done using a 
standardised questionnaire. They defined erectile dysfunction as the ‗‗failure to attain 
as well as maintain an erection satisfactory for sexual intercourse‘‘. For their study 
they classified men into various groups based on their reply to  could achieve a 
satisfactory erection: 
a. No erectile dysfunction : if the reply was ‗‗always‘‘,  
b. Mild ED when the reply was -Usual 
c. Moderate ED when the reply was - sometimes 
d. Complete ED when the reply was -never.  
They found that prevalence of erectile dysfunction increased with the increase in age 
and this was uniformly seen in all the four mentioned  countries.. The study also 
found  a  association between lower urinary tract symptoms and erectile dysfunction. 
This study further found an association between erectile dysfunction and other 
factors such as smoking, diabetes, coronary artery disease and depression. The 
incidence of erectile dysfunction  was found  as Brazil (15%), Italy (17%), Japan 
(34%) and Malaysia (22%) (19).  One of the most notable risk factors for erectile 
dysfunction was age. Men in the age group 50-60 years were two times more likely 
to develop erectile dysfunction while comparing to men in the age group 40-50 
years. This risk for the development of  erectile dysfunction increased by five times 
for men in the age group 60-70years (20). Similar to erectile dysfunction, the 
prevalence of benign enlargement of the prostate also increases from eight percent 
in the  fourth to more than eighty in the eighth decade (15).  A cross-sectional 
evaluation of the association between sexual function and lower urinary tract 
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symptoms in a survey noted that sexual satisfaction inversely  correlated  with 
increasing age and lower urinary tract symptoms (21). The  risk of erectile 
dysfunction increased with the severity of LUTS,  and this association was greater 
than known risk factors (eg. coronary artery disease, respiratory problems and 
smoking). This further highlights that ED is an important aspect to enquirein patients 
who present with LUTS (22).   
The Epidemiologia de la Dysfuncion Erectile Masculina (EDEM) survey: A study of 
2476 men from Spain in the age group 25–70 years. It was a community based 
study. Interview was conducted at home. They had  to answer a self-administered 
questionnaire (23). The prevalence of erectile dysfunction  in this group was 18.9%. 
This was based on the erectile function subgroup of the International Index of 
Erectile Function. There was significant correlation between the ageing  of the 
patient and risk of development of erectile dysfunction.. The study also detected 
other  risk factors that were  associated with erectile dysfunction such as the 
presence of prostatic ailments, diabetes mellitus, essential hypertension, peripheral 
vascular disease, coronary artery disease, pulmonary disease,  rheumatism and 
allergy.  A correlation was found  between the severity of lower urinary tract 
symptoms according to the IPSS scale and the possibility of erectile dysfunction. 
After adjusting for age the odds ratio for the development of erectile dysfunction was 
calculated. It showed the OR to be 2.39  in those with  moderate symptoms but it 
increased in the group with severe symptoms to 6.47. 
The  Alf-One study included nearly 3000 male with lower urinary tract symptoms 
from five countries. The study also showed that one of the major risk factors for the 
development of ejaculatory and erectile dysfunction was the presence of lower 
urinary tract symptoms preceded by aging (24).  The Alf-One study was similar with  
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the findings of the Multinational Survey of the Ageing Male survey. The Alf-One 
study found that the risks of erectile dysfunction and ejaculatory dysfunction are 
double  in men with severe lower urinary tract symptoms than those without severe 
lower urinary tract symptoms They further found that the patients with severe lower 
urinary tract symptoms had six times the risk for development of painful ejaculation. 
Abnormal erectile and ejaculatory responses has a considerable adverse effect on 
the QoL (quality of life)i those men who were sexually active previously. This causes 
significantly increased levels of anxiety and depression in these people (25). Hence 
the preservation of sexual function in the aging male is a vital component of the 
quality of life. 
The  largest study conducted to  till date is the(Multinational Survey of the Aging 
Male) MSAM-7 survey. This study was conducted on an international scale and was 
designed to evaluate the association between with lower urinary tract symptoms with 
sexual function in a detailed and meticulous fashion (1). In contrast to  previous 
studies that concentrated mainly on the assessment of erectile dysfunction, the 
MSAM-7 survey incorporated evaluation of all domains of sexual activity. It not only 
studied  on the aspects of ejaculatory dysfunction (EjD) but also on the impact of 
lower urinary tract symptoms on the QOL (quality of life). The questionnaires were 
sent to more that 14,000 men in the age group  50–80 years. This study  included   
the populations of seven countries ( France, Italy, United kingdom, Germany, 
America, Spain and the Netherlands which possessed different customs and life 
style. The incidence of erectile dysfunction  increased gradually and considerably 
with the severity of lower urinary tract symptoms (p < 0:001). They found the 
prevalence of severe lower urinary tract symptoms -82.5% , moderate - 65.8% 
whereas mild LUTS was 43%. Aging led to an increase in the erectile dysfunction (p 
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< 0:001). The  association  between severity of lower urinary tract symptoms and 
erectile dysfunction was seen inspite of the  presence of co morbidities 
(hyperlipidemia, hypertension, diabetes mellitus and cardiac disease). There was a 
strong association between the severity of lower urinary tract symptoms and of both 
erectile and ejaculatory dysfunction. Among men presenting with diabetes mellitus or 
hypertension, a greater  prevalence of erectile or ejaculatory dysfunction was seen 
when  compared with men without these conditions. The associatin between sexual 
dysfunction and severity of lower urinary tract symptoms remained apparent in each 
age group. The approximate percentage of patients with lower urinary tract 
symptoms who wanted  medical interventions for their condition  was only 19% in the 
MSAM-7 survey. This suggestsed a  lack of motivation or enthusiasm among these  
groups to visit their physicians. Increased awareness is required in these elderly 
male patients  to diagnose lower urinary tract symptoms due to their ignorance. 
Those with moderate or severe lower urinary tract symptoms should be meticulously 
enquired  regarding both erectile and ejaculatory function. Reliable and validated 
investigative tools are available to rule out the sexual dysfunctions in male genders . 
The extensive accessibility of treatments for erectile dysfunction  may help these 
group of  patients to discuss issues of sexual dysfunction   confidentially with their 
doctors.  The disadvantages associated with some of  the treatments options 
available for benign prostatic hyperplasia, including effects on sexual function, 
should be informed to the patients and their relatives in well in advance. Many 
epidemiological trials  have shown that erectile dysfunction is strongly linked to the 
severity of lower urinary tract symptoms and is not dependent on age or coronary 
artery diseases (26–28). 
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Figure 4: Diagram showing the various pathogenic mechanism 
The mechanisms for the association of erectile dysfunction and Lower urinary tract 
symptoms is not  yet defined. Various theories have been proposed which includes: 
1) The pathway involving the (NOcGMP) Nitric oxide–cyclic guanosine 
monophosphate 
2) Enhancement of (ROCK) RhoA–Rho-kinase signalling,  
3) Hyperactivity of the autonomic nervous system 
4) Atherosclerosis of the pelvic vessels.  
1. The pathway involving the (NOcGMP) Nitric oxide–cyclic guanosine 
monophosphate: This pathway conducts the activity  of regulating  relaxation of 
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smooth muscle in penis  and erection  has been well characterised (29). 
Evidence exists,for  NO which plays a major role  in the regulation of smooth 
muscle tone of bladder, prostate, and urethra (30). Release of nitric oxide 
activates a process which leads to formation of cGMP. This leads to decrease in 
the level of intracellular calcium whereby causing relaxation of smooth muscles. 
Protein such as cGMP- specific protein kinase are enhanced. Two types of  NO 
synthase (NOS)-  neuronal NOS (nNOS) and endothelial NOS (eNOS) have 
been seen in the  in the tissues of  corpora cavernosum. The role of nitric oxide in 
prostate related lower urinary tract symptoms have been studies in vivo on 
cultured prostate , urinary bladder and urethral smooth muscle.(31)  These  
findings from such study may help one to understand the mechanism which is 
caused by decrease in the  generation of nitric oxide. This leads to gradual 
deterioration of nerves and the overlying epithelium. Studies have shown that 
essential hypertension and the metabolic syndrome also has a association with 
the lower urinary tract symptoms and erectile dysfunction. (32). 
2. The mechanism of RhoA/Rho-kinase:   
The smooth muscle tone is maintained through dual mechanism – 
a) Calcium-dependent pathway   
b) RhoA–ROCK calcium-sensitising pathway. Activation of RhoA–ROCK pathway 
causes  decrease in the smooth muscle relaxation resulting in erectile dysfunctin 
and LUTS. In a similar manner the RhoA–ROCK signalling in the penile tissue 
was seen to be increased in conditions such as diabetes mellitus. This process is 
exaggerated in conditions associated with erectile dysfunction. An increase in the 
signal of muscarinic receptor causes activation of the Rho A pathway which 
causes involuntary bladder contractions.(33,34). 
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3. Hyperactivity of the autonomic nervous system :  
Autonomic hyperactivity is a nervous stimulation that causes  exaggeration of 
parasympathetic and sympathetic system. It is known that the α -adrenoceptor 
system  plays an important role in the pathophysiology of ED and LUTS secondary 
to BPH (35) with increased sympathetic activity. Various α1-adrenergic receptors 
present in prostate, urinary bladder and penile tissue mediates the tone of the 
vessels and the smooth muscles (36). In an animal study using rats where the rats 
were fed with a fatty diet. This study revealed that the rats developed 
hyperglycaemia and increased resistance of insulin along with increase in the 
proliferation of cells. These led to  increased contraction of the α receptors and  -
adrenoceptor-mediated contraction and progress of benign prostatic 
hyperplasia(37).  These along with other pathways like  advanced end results  of 
glycation,  reactivation of  oxygen species probably affect both lower urinary tract 
symptoms and erectile dysfunction. 
4. Atherosclerosis of the pelvic vessels:   
Development of atherosclerosis of urinary bladder, genitalia and prostate is the 
harbinger to all of the above described theories.  The development of pelvic 
atherosclerosis causes reduction of  signals for nitric oxide and  upregulation of  
the RhoA/ROCK pathway. It also acts as a component of the autonomic hyper 
activity and  metabolic syndrome. The possibility of acquiring   risks for erectile 
dysfunction  and atherosclerosis, like hypertension and diabetes mellitus, can  
also affect lower urinary tract symptoms and benign prostatic hyperplasia (38,39). 
Age and sexual function has a strong bondage and the younger population were 
more sexually activity. (40). A study comprising of 2801 men in the age group 17 to 
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93 years revealed, 5% with impotence in age group 50-59, compared to which 35% 
in the age group 70-79 and 59% in more than 80 years. In a survey conducted with  
2801 men in private practice aged between 17 to 93 years revealed, 5% of men in 
their 50s with impotence,  in comparison  with 35% in their 70s and 59% in their 80s 
(41). 
A study conducted in  2011 in France randomly selected  men in the age group  50 – 
80 years (21). They concluded that not only the desire for intercourse but also 
frequency of sexual activity was found to be linked with age (p<0.001),  involving 
erectile and ejaculatory function. It was also evident that men with lower urinary tract 
symptoms were more likely to suffer with   sexually dissatisfaction   than those 
without symptoms. The possibility of having  sexual dissatisfaction appeared to 
increase with the severity of  lower urinary tract symptoms (21). 
 Aging impairs the   progressive function of the hypothalamic-pituitary-gonadal axis. 
In male, this gradual deterioration shows a significant difference in the age of onset,   
rapidity and intensity of the decline between  the individual . The above  syndrome is  
known as ADAM (androgen decline in the aging male), LOH (late-onset 
hypogonadism), or TDS (testosterone deficiency syndrome). 
Hypogonadism in men ,is clinically  characterised by a reduced concentration of 
serum testosterone, where patients present with various  signs and symptoms. This 
includes erectile dysfunction, decreased libido , decreased in the amount of 
ejaculate, loss of hair of the face and body, lethargy, decreased lean body mass, 
decreased bone density, increased body fat, fatiguability and anaemia (42,43). 
Hypogonadism in adult men is often  given less importance because inspite of the 
presence of associated symptoms, these men are often ignorant of  their symptoms. 
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Very often they  attribute these symptoms  to miscellaneous causes, including 
ageing (42). The total testosterone (TT) has not been used as a standard criteria for 
defining hypogonadism as the cut off level for the normal concentration of serum 
testosterone is not defined (44). Hypogonadism has been defined by Vermeulen as 
less than 319 ng/dl i.e  two and half standard deviations less than the mean normal 
total testosterone in young individuals (45). Testosterone level less than  300 ng/dl is 
associated with decreased bone mineral density (43). Others have defined 
hypogonadism as total serum testosterone less than 325 ng/dl (44). 
 
Figure 5:  showing the effect of age on the production, transport and metabolism of 
testosterone (T). 
The figure depicts that the LH (Luteinizing hormone) plays an important role on the 
regulation of testosterone production.  With the gradual onset of aging of the pituitary 
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and hypothalamus causes decrease in the production of  GNRH (gonadotropin-
releasing hormone) and LH (LuteinizingHormone). Only 2 % of the testosterone 
either circulates, rest is protein such as SHBG (sex hormone binding globulin) or 
albumin. With the onset of agint the production of sex hormone binding globulin  
increases.  Bioavailable testosterone becomes activated and gets  converted to 
other hormones like ( estradiol (E2), dihydrotestosterone, dehydroepiandrosterone). 
FSH, follicle-stimulating hormone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 39 
 
 
 
 
 
Materials and methods 
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This was a prospective study done at the Urology department of a tertiary care 
hospital, for a period of one year from August 2012 to July 2013. 
 It was approved by the institutional review board, (Institutional research board no: 
8069/6.8.2012).  
 
Inclusion criteria: 
Males more than 50 years attending the LUTS clinic were included as the case 
group (LUTS) and matched patients without LUTS were enrolled as the control group 
(No LUTS).  
 
Exclusion criteria: 
Those who were on medical therapy for lower urinary tract symptoms, patients with 
penile deformity, and  pre existing diagnosis of  erectile dysfunction and depression 
(who was evaluated  using PRIME- MD questionnaire) were excluded from the 
study.  
 All these patients were interviewed by the primary observer after obtaining consent.  
 
 All base line data recorded the client‘s status about demography, socioeconomic 
status, Anti social activities like substance abuse (smoking, alcohol), co morbidities 
(Type 2 DM, hypertension, chronic renal failure, heart diseases) and medical history. 
They underwent a physical examination (height, weight, pulse rate, blood pressure, 
examination of the external genitalia and a digital rectal examination) and blood 
investigations  was done  for glucose, lipid profile, creatinine and serum 
testosterone.  An uroflowmetry with post void residual urine was performed on them.  
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To objectively evaluate the severity of LUTS, the International Prostate Symptom 
Score (IPSS) and to evaluate sexual dysfunction, the International Index of Erectile 
Function-15 questionnaire was administered. The International index of the erectile 
function is the gold standard measure of the sexual function in males. This tool is 
being used in many trials for erectile dysfunction (46). The Primary Care Evaluation 
of Mental Disorders screening questionnaire for depressive symptoms (PRIME-MD)  
was used as a instrument to assess psychosocial health and depression (47). When 
the patient was found to be suffering from depression he was excluded from the 
study. Later the results of the IPSS, PRIME-MD questionnaire, IIEF-15 and their 
correlation with lower urinary tract symptoms were statistically analyzed. Uroflow 
rates diagnostic implications and limitations 
 Uroflowmetery is a noninvasive  first line screening test for individuals who have 
lower urinary tract symptoms. It gives quantitative and objective information that can 
help in understanding the etiology of lower urinary tract dysfunction. 
There are some prerequisites for a uroflowmetry. Privacy should be provided during 
the test. Instruction to void should be given when the individual has a  normal urge to 
void. Artifacts must be taken into account when recording the values of uroflowmetry. 
Patients‘ frequency volume chart values must be compared with results of 
uroflometery to know if these values represent his day to day normal voids. Patient 
should be asked if the void is representative of his normal day to day void. 
What does a normal uroflow represent? Normal uroflow has a smooth bell shaped 
(arc-shaped) graph. The gentle curves rather than rapid changes in amplitude are 
the function of detrusor function which is a smooth muscle and does not show rapid 
variations. 
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Factors that result in deviation from normal pattern of flow rate: Decrease in detrusor 
contractility can result in a smooth curve of lower amplitude. Similarly, compressive 
obstruction with increased urethral opening pressure due to benign prostatic 
hyperplasia shows a flattened asymmetric curve with slowly declining part. 
Constrictive obstruction resulting in reduced lumen (e.g. stricture) size produces a 
plateau like flow curve.  
Rapid changes in flow rates may result due to variety of causes. Variations in driving 
force such straining, rapid changes in outlet resistance such as contraction or 
relaxation of striated sphincter or pelvic floor, urethral compression or interference at 
meatus can all result in rapid changes in flow rates. Any artifact that causes 
interference in urinary stream form meatus to the flowmeter can potentially cause 
rapid fluctuation in flow rates e.g. movement of stream across the surface of funnel 
or movement of patient. 
Factors other than detrusor contraction and bladder outlet resistance that affect the 
uroflow are voided volume and technical considerations. Maximum flow rates 
(Qmax) depends on voided volume. Small volumes (< 150 ml) and large voided 
volumes (.500ml) may be the reason for low Qmax. Technical specifications for 
measuring flow rates have been standardized by International Continence Society 
(48). 
 LUTS was determined by IPSS. IPSS, a validated eight-questionnaire  scale for 
assessing LUTS. It is based on factors like  decrease in the flow of urine, incomplete 
voiding,  increased frequency,  urgency, straining to void and nocturia. The first 
seven questions have responses that ranges from 0 to 5, resulting in an overall 
score of 0 to 35. Symptoms were grouped as absent when the IPSS score was less 
than zero. It was grouped as mild when the score was less than or equal to seven,  
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moderate when the score was between 8 to 19 and severe when the score was 
more than or equal to 20. The eighth question was used to assess Quaity of Life. 
The response ranged from 0 to 6. 
Sexual dysfunction was assessed using the International Index of Erectile Function 
(IIEF) by Rosen and colleagues. The IIEF contains 15 questions that quantify five 
domains of sexual function— sexual desire, erectile function, intercourse 
satisfaction, orgasmic function and overall satisfaction. It is the most widely used 
questionnaire . This has been useful to clinicians in day to day clinical practice 
specifically  for the evaluation of erectile dysfunction. The instrument classifies ED 
severity into five categories: No ED (22 to 25),  mild (17 to 21), mild to moderate (12 
to 16), moderate (8 to 11) and  severe (5 to 7).  It is 15 questions, standardized scale 
for evaluation of male sexual function that examines separate domains of Erectile 
Function (1 to 5,15), Intercourse Satisfaction (6 to 8),  Orgasmic Function (9-10),  
Sexual Desire (11-12), Overall Satisfaction (13,14). 
. 
 
To assess their psychosocial health the Primary Care Evaluation of Mental Disorders 
screening questionnaire for depressive symptoms (PRIME-MD) instrument wasgiven 
to the case group. It has 2 components, the first is a patients self-administered 
questionnaire. The second component is used by the physician for the individuals 
who test positive to the first set.  (47). They are scored as: 
a) less than 4 -  no treatment warranted 
b)  5-15 – intermediate , treatment based on the impairment of function 
c)  >15 - warrants treatment eg antidepressant, psychotherapy. 
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The cut off values of the variables. 
 The normal values of the blood tests was compared with the laboratory values at the 
institution.  
Serum creatinine  
> 1.4mg % was considered as chronic kidney disease.   
Blood sugar values  
  Fasting blood sugar =  70-100mg%,  
Glucose 2 hr post food < 140mg%.) 
 Lipid profile:   
Total cholesterol < 160mg% 
HDL - 40-60mg% 
LDL - < 100mg% 
Serum triglyceride < 150mg%. 
 
 
 Normal blood pressure according to JNC 7 is less than 120/80mmHg. 
 
A testosterone level of 212-755 ng/dl is the laborotary reference range for the 
institution laboratory.  A value less than 212 ng/dl was considered as low. In such 
patients the free and bioavailable  testosterone levels was calculated.  
 
Statistical analysis: These two groups were compared using Stata 10.  Univariate 
analysis was done by 1) Chi square  and 2) Two sample Mann – Whitney U test. 
Multivariate regression analysis using logistic regression for dichotomous variables 
was performed.  
Page | 45 
 
 
The sample size was calculated based on a power of 90% and assuming the 
prevalence of sexual dysfunction in men more than 50 years with lower urinary tract 
symptoms to be 49% (1).  A sample size of 134 was calculated for both the arms. 
The association of lower urinary tract symptoms and sexual function scores were 
calculated not only for the total sample but also in both the groups,  age cohort (fifty 
to fifty-nine years, sixty to sixty nine and more than seventy years). The presence of 
various co morbidities (hypertension, coronary artery disease, diabetes,  
hyperlipidemia). In addition the relationship to addictions such as tobacco chewing  
and consumption of alcohol with the primary variable. The association of body mass 
index (BMI) and total cholesterol levels with sexual dysfunction was also evaluated 
Study design:  It was a case control study. 
 
The formula used to calculate the sample size was- 
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Results and observations 
 
Page | 47 
 
Christian Medical College, Vellore
LUTS - 134
sexually inactive 
63
sexually active
71
Total - 276 
No  LUTS - 134
sexually inactive
31
sexually active 
103
Excluded - 8
 
Figure 6:  Consort diagram showing the distribution of groups 
Out of 276 consecutive patients who attended the urology OPD, eight patients were 
excluded. There were 134 patients in both the arms. 71 patient s were sexually 
active in the LUTS group whereas 103 were active in the no LUTS group.  
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Demographic profile 
 
Table 1 : table showing the demographic profile in both the groups 
 
The age was not matched in both the groups but this was adjusted by taking age 
adjusted multivariate analysis. Both the groups were all matched for their co morbid 
conditions (presence of both diabetes mellitus and hypertension, diabetes and 
hypertension alone or  addictions.  
 
 
 LUTS 
(n = 134)  
No LUTS 
(n = 134)  
p 
value  
Age  50-59  60(45%)  83(62%)   
0.014  60-69 55(41%) 41(31%)  
>70  19(4%)  10(7%)  
Co- morbidities  DM + Hypertension  17(13%)  22(16%)   
 
0.687  
DM  19(14%)  21(16%)  
Hypertension  20(14%)  15(11%)  
No co morbidities  78(58%)  76(53%)  
Addictions  Smoking  68(51%)  42(31%)  0.37  
Alcohol  4(3%)  5(4%)  0.86  
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  LUTS 
(n = 134)  
No LUTS 
(n = 134)  
p 
value  
 
 
Education  
Uneducated  3(2%)  3(2%)   
 
0.647  
Upto 10th  44(33%)  35(26%)  
11 – 12th  39(29%)  40(30%)  
Graduate and 
above  
48(36%)  56(42%)  
Married  126(94%)  132(99%)  0.149  
 
Table 2 : table showing the education and the marital status in both the groups 
 
Both the groups were well matched for the education status. In evidence  the 
presence of a partner, and the level of education had similar effect in both the 
groups. 
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Lower urinary tract symptoms versus sexual activity 
 
 
 
 
 
Diagram 3: Pie diagram showing sexual activity in both the groups 
As shown in the pie diagram 76% of men in the No LUTS group were sexually active 
when  compared to 53% in the LUTS group and this was statistically significant 
(p=0.001) 
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Age versus sexual activity 
 
                                             Age in years 
Diagram 4: showing Age versus sexual activity 
 
The bar diagram showing the age in years versus the sexual activity. As expected 
the sexual activity decreases with age. But the maximal affect of the decline in 
sexual activity was seen in the younger group, aged 50-70 years, with lower urinary 
tract symptoms ( LUTS). This was also statistically significant (p=0.001) 
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Sexual function (IIEF-15) versus LUTS 
 LUTS (n=71) 
Median (IQR)  
No LUTS (n=103) 
Median (IQR)  
p value  
Erectile function  23 (17 - 24)  24 (20-25)  0.05  
Orgasmic function  8 (8 – 9)  8 (7 – 8)  0.41  
Sexual desire  7 (6 – 8)  8 (7 – 8)  0.009  
Intercourse satisfaction  10( 7 - 10)  10 ( 9 – 12)  0.001  
Overall satisfaction  8 ( 6 – 8)  8 ( 7 – 8)  0.017  
 
Table 5: Showing the components of IIEF vs. LUTS 
 
 
As shown in the above table Lower urinary tract symptoms had a significant impact 
on the erectile function, sexual desire, intercourse satisfaction and also overall 
satisfaction of the IIEF- 15. 
According to Rosen et al (1)  an IIEF score of less than 14 is considered to have 
erectile dysfunction (ED). 
 An age adjusted multivariate analysis was done to see the effect of age, LUTS, co 
morbidities (presence of diabetes mellitus, hypertension), hyper cholesterolemia    
and serum testosterone effect on the erectile function. As shown in table 6 Lower 
urinary tract symptoms continued to be a significant factor affecting the erectile 
function. Though hypercholesteremia was a significant factor affecting the erectile 
function, the multivariate analysis didn`t review it. S. testosterone less than 212ng/ml 
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was taken as cut off value and an age adjusted multivariate analysis was taken to 
see the effect of testosterone on the erectile function. It was concluded that there 
was no significant effect of serum testosterone on the erectile function.  
 
Risk factors  Age adjusted 
OR (95%CI)  
p value  Multivariate 
OR (95%CI)  
p value  
Age                   50-59 
                         60-69 
                         >70  
  1 
5.94 (3.1-11.5) 
10.5 (3.9-28.6)  
 
<0.001 
<0.001  
LUTS                           2.75 (1.5-4.9) 0.001  2.96 (1.6-5.5) 0.001  
BMI                   <20    
                       20-25 
                          >25                                                    
1.63 (0.9-3.1) 
3.29 (1.1-10.2) 
1
0.04 
0.12  
1.76 (0.9-3.5) 
3.87 (1.1-13.2) 
1  
0.10 
0.03  
DM                                                                                                                 1.67 (0.9-3.1) 0.09  2.04 (1.0-4.1) 0.06  
Hypertension                                                           1.19 (0.6-2.2) 0.57  1.07 (0.05-2.2) 0.85  
Hypercholesterolemia                             0.50 (0.3-0.9) 0.02  0.57 (0.3-1.1) 0.08  
Testosterone 0.82 (0.3-2.4)  0.72  0.59 (0.2-1.9)  0.38  
 
 
Table 6: Showing prevalence of  risk factors for erectile dysfunction 
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                                 Age in years 
Diagram 7 showing: Erectile dysfunction vs. Severity of LUTS and age group 
An attempt was made to find the association between the severity of lower urinary 
tract symptoms and the erectile function. As shown in the diagram 7, median IIEF 
score for erectile function was plotted against the severity of LUTS and age group. 
Severity of LUTS was classified as IPSS score less than 19 and more than 20. It was 
seen that the maximum effect of severity of lower urinary tract symptoms on the 
erectile function was seen in the age group 60- 70 years. 
Age (years)  LUTS  
Median (IQR)  
No LUTS  
 Median (IQR)  
50-59  378 (292 - 500)  338 (283 – 451)  
60-69  396 (311 – 502)  340 (278 – 421)  
>70  445 (288 – 572)  353 (331 – 391)  
 
Table  8: showing the median testosterone values 
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The median testosterone value in both the groups were around 350ng/ml. This also 
shows the average testosterone value in the elderly Indians. 
When enquired into the reason of not being sexually active, more than 50% of the 
patients cited due to  the presence of LUTS as a rational behind it . Whereas those 
in the no LUTS group cited various religious belief and age to be the factor for being 
sexually inactive 
 LUTS (n=63)  No LUTS (n=31)  
LUTS  39  0  
Religious  belief  8  10  
Age  9  11  
Joint family  1  0  
Spousal/partner factor  3  7  
Unmarried  3  3  
 
Table 9: showing the reason for not being sexually active 
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Discussion 
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Lower urinary tract symptoms (LUTS) and sexual dysfunction are common problem 
of the aging population. This is the first study evaluating Indian patients with  lower 
urinary tract symptoms and sexual dysfunction.  The study showed that sexual 
activity is commoner in the aging men. When enquired they replied that there was an 
increased level of anxiety in association with these problems.  
Our study found a strong association between lower urinary tract system and sexual 
dysfunction. This was also showed by the study by Rosen et al (1) and Diokno et al 
(49). We used  standardised and validated scales for measurement of lower urinary 
tract symptoms and sexual dysfunction. These scales were  administered by the 
principal investigator in all cases.  The incidence of sexual dysfunction with lower 
urinary tract symptoms 47% in the present study. This is well comparable to the 
prevalence of 49% (46) in the western literature by Rosen et al (1).  But unlike the 
study by Rosen which was multinational community based with questionnaires being 
mailed to the people, this was single institution based and the performa were filled by 
the primary investigator. 
 
Age is considered as an important risk factors for the development of erectile 
dysfunction. In comparison to men in the age group 50-60 have twice the risk for 
development of erectile dysfunction in comparison to men in the age group 40-50 
years. This risk further rises five times for men in the age group 60-70 years. 
Numerous  community-based surveys (1,11,46,49) have shown that the age of the 
men considered for a study accounts for difference in the prevalence of erectile 
dysfunction and lower urinary tracts symptoms. The National Health & Social Life 
Survey found  that lower urinary tract symptoms  is a major risk factor for 
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development of erectile dysfunction. An odds ratio (OR) of 3.13 was seen in 1410 
men in the age group 18–59 yr (46). The Krimpen survey while evaluating men more 
than 50 years of age found that the presence of severe ejaculatory and erectile 
dysfunction to be 10 times higher in men in the aged more than 70 years in  
comparison to the 50–54 yr of age Using logistic regression This study using logistic 
regression   further demonstrated the odds ratio to be 7.5 in the association between 
severe LUTS and  ED. The odds ratio was 4.2 between severe LUTS and 
ejaculatory dysfunction (50). 
 The present study showed that men without lower urinary tract symptoms were 
significantly more sexually active. It showed about 50% of male with LUTS were 
sexually inactive whereas only  24% of men without LUTS were sexually inactive, 
this was statistically significant (p=0.001). This could possibly be due to the lack of 
effective primary care in India and the consequent delayed management of LUTS. 
Earlier detection and optimization of the general health and lower urinary tract 
symptoms   may significantly improve men`s health in the country.  
The exact pathway  of sexual dysfunction in men with LUTS is not well understood. 
Various literature have proposed three common pathophysiologic mechanisms (11) :  
1) The change in the NO(nitric oxide) pathway in the prostate   
2) Atherosclerosis of pelvic vessels  
3) Hyperactivity of the autonomic nervous system.  
It is proposed that risk factors for erectile dysfunction such as diabetes mellitus, 
smoking, dyslipidaemia and hypertension reduces the activity of NOS (nitric oxide 
synthase) in prostate and bladder. This causes reduction in NO level. Evidence for 
this hypothesis can be derived from studies in humans (26) and animal models (30) .   
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  Hyperactivity of the autonomic nervous system most likely plays a  direct role in 
altered voiding and erectile function (46).  
Lastly, atherosclerosis which is a common cause of erectile dysfunction, could result 
in reduced perfusion of the urinary bladder and  an associated increase in smooth 
muscle cell proliferation and contractility there by leading to lower urinary tract 
symptoms (51) . 
 The Baltimore Longitudinal study of ageing men found a strong association between 
Benign prostatic hypertrophy (BPH), obesity and diabetes mellitus (52).  Our study 
showed most of the patients in both theLUTS and no LUTS groups to be in the 
acceptable BMI range. There was no association between LUTS, obesity and co 
morbid conditions like DM, hypertension. This was similar to the finding of Rosen et 
al (1) which showed that the association between sexual dysfunction and lower 
urinary tract symptoms is not dependent on co morbidities such as hypertension 
diabetes mellitus, coronary artery  disease and hypercholesterolemia. 
The various components of the sexual dysfunction in the International Index of 
erectile function-15 (sexual desire, erectile and orgasmic function, intercourse and 
overall satisfaction)  was significantly associated in the  patients with LUTS which 
correlated well with the MSAM (Multinational Study of the Aging Male-7)  study (1).  
 When enquired about the reason of not being sexually active the  majority of 
patients in the LUTS group cited LUTS to be the cause. Whereas those without 
LUTS cited various reasons like age, religious beliefs, various  
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The Massachusetts Male Aging Study observed that there was  an association of 
sexual dysfunction with smoking in addition to other risk factors, like hypertension, 
diabetes mellitus and coronary artey disease (53). A similar association between 
sexual dysfunction with comorbid conditions  and substance abuse was not seen in 
our study This may be due to the fact that this study was not powered to study such 
an association. 
 The multinational survey of the aging male-7 (1) study, using the response to ,DAN-
PSS questionnaire  showed that erectile dysfunction was strongly associated with 
the severity of lower urinary tract symptoms( p < 0:001). Our study also showed that 
the erectile dysfunction had an inverse relation with the severity of lower urinary tract 
symptom. It showed that the incidence of erectile dysfunction was significantly high 
amongst those with higher IPSS score in the age group 60 – 70 years (p=0.02).  
Both Similar results were also seen by other studies that reported a higher incidence 
of erectile and ejaculatory problems in men with moderate-to-severe LUTS (47). 
Interestingly our study found that the average serum testosterone level in  men more 
than 50 years was found to be 384 ± 159 ng/dl as compared to 437.8  ±  180.1ng/dl 
in Americans, as in the study by Araujo AB et al (54) 
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 Association between LUTS and ED in population based studies:  
Year/Author Name of 
study 
Sample 
size 
Assessment  Prevalence  Association  
1994, 
Feldman et 
al (25)
 
MMAS 1709 
(40-
70yrs) 
Structured 
interview of 
LUTS and ED 
ED:52%  
(severe 
LUTS-66%) 
ED: age, 
hypertension, 
depression, 
LUTS, 
medicines 
1999, 
Lauman etal 
(55)
 
NHSS 1410 
(18-
59yrs) 
Self reports of 
LUTS 
1 question on 
ED 
SD:31% 
ED:10% 
 
ED - LUTS 
(odds ratio- 
3.13) 
2001, 
Blanker et al 
(22)
 
Krimpen 
survey 
1688 (30 
– 80 yrs) 
IPSS 
4  ICS-sex 
question 
ED: 11% 
 
 EjD: 13% 
ED: LUTS, age, 
smoking , CVS 
and pulmonary 
problem 
ED – LUTS 
Odds Ratio 7.5 
2000, Braun 
et al (56)
 
Cologne male 
survey 
4477 
(30-80 
yrs) 
IPSS 
18  KEED 
questions 
LUTS: 44% 
 
ED: 19% 
 
ED: LUTS, DM, 
hypertension,  
Pelvic sugery  
2005, Li  et 
al (57)
 
Asian Survey 
of Aging 
Males 
 (50-80 
yrs) 1155 
IPSS 
DAN-PSS-sex 
IIEF 
ED: 63%( 
57% - 
bothered) 
ED: age, LUTS, 
DM, 
hypertension 
ED : LUTS 
Odds ratio 
:3.17 
2010, 
Holden et al,  
(58)
 
 Australian 
male 
(telephonic 
survey) 
 (>40 yrs) 
5990 
IPSS 
single question 
of ED 
LUTS : 16% 
ED: 21% 
ED/LUTS 
prostate 
related 
disease & 
androgen 
deficiency: 
34% 
ED : DM, 
Cardiovascular 
disease 
LUTS : 
Hypertension 
2003, Rosen 
et al (1)
 
(USA/Europe) 
Multinational 
Survey of 
Aging Male 
12,815 
(50-
80yrs) 
IPSS 
DAN-PSS-sex 
IIEF 
LUTS: 90% 
ED : 49% 
 
ED and EjD: 
Severity of 
LUTS, age 
ED- LUTS 
Odds ratio 7.67 
2013, 
Present 
study 
Indian male 268 (>50 
years) 
IPSS 
IIEF 
SD: 47% 
LUTS and 
31% no 
LUTS 
SD: age, LUTS 
ED: severity of 
LUTS 
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Strengths 
a) 1st study in India showing the association of lower urinary tract 
symptoms with Sexual dysfunction in male more than 50 years of age 
b) Scales for the measurement of LUTS and Sexual dysfunction were 
internationally validated and standardized.  
c) Questionnaires were filled by the primary observer 
d) Association of sexual dysfunction with testosterone levels 
 
Limitations 
a) Age was not matched, however a multivariate analysis was done to overcome 
this limitation 
  
b) The present study was not powered to study the associated risk factors for 
sexual dysfunction 
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Conclusions 
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• The prevalence of sexual dysfunction amongst men with LUTS was 47% 
whereas it was 24% in men without LUTS 
• There is significant association of LUTS with sexual dysfunction in men >50 
yrs, especially in the age group 50-70 yrs. 
• LUTS had a significant impact on most of the domain of the IIEF 15. 
• Severity of lower urinary tract symptoms correlated with the severity of erectile 
dysfunction in the age group 60-70 yrs. 
• The mean testosterone in our study for males  more than 50 years is 
350ng/ml. 
• LUTS was the reason for not being sexually active amongst the LUTS group. 
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Annexure: 
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Proforma: 
Name 
Hospital number 
Age 
Occupation 
Address 
Phone number 
(PLEASE TICK THE APPROPRIATE COLUMN) 
Marital status 
Married     
Widower, separated, divorced. 
 Single 
          Promiscous behaviour                                  
 
Children 
Sexually active 
 
Socioeconomic status: 
Govt. Service 
Businessmen 
Farmers/coolies (daily wagers) 
Retired 
Unemployed 
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Education 
<10th  
10+2 
Graduate and above 
Uneducated 
Comorbid conditions 
Diabetes 
Hypertension 
Heart disease 
CKD 
         Depression (evaluated using PRIME MD questionnaire) 
Smoking status : 
Never 
Former smoker 
Current smoker 
No. Of cigarettes per day 
Alcoholic drinks 
None 
Yes 
No. Of pegs per day 
Physical activity  
Less than average 
Page | 77 
 
Average 
More than average 
Previous surgeries: 
(If  yes mention the surgery-)  ---------------------------- 
 
General Examination: 
Pulse 
BP 
Weight 
Height 
BMI 
 
External genitalia:  
 Pubic hair: (Tanners grade) 
 Testis size in cm (length x breadth) 
Penis 
Penile hygiene 
Are you aware that ca penis is caused by bad penile hygiene 
 
DRE (Digital rectal examination) 
 
 
Laboratory Values: 
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RBS/AC/PC: 
S. Creatinine: 
Urine Microscopy: 
Lipid profile: 
  Total cholesterol 
  Triglyceride 
  LDL 
  HDL  
Serum testosterone: 
X- ray KUB (kidney ureter bladder): 
Uro flow and  PVR (post void residue) 
 
LUTS: IPSS (International prostate symptom score) 
Absent or minor 
Moderate 
Severe 
IIEF (International index of Erectile function) 
Scoring Algorithm for IIEF 
All items are scored in 5 domains as follows: 
Domain Items Range 
Score Max 
Score 
Erectile Function  1, 2, 3, 4, 5, 15   0-5 30 
Orgasmic Function 9, 10  0-5 10 
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Sexual Desire  11, 12  0-5 10 
Intercourse 
Satisfaction 
6, 7, 8  0-5 15 
Overall Satisfaction 13, 14  0-5 10 
 
 
Clinical Interpretation 
I. Erectile function total scores can be interpreted as follows: 
Score Interpretation 
0-6 Severe dysfunction 
    
7-12 
Moderate 
dysfunction 
    
13-18 
Mild to moderate 
dysfunction 
    
19-24 Mild dysfunction 
    
25-30  No dysfunction 
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1. Over the past 4 weeks, how often were you able to get an erection during sexual activity?  
0 No sexual activity  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never 
2. Over the past 4 weeks, when you had erections with sexual stimulation, how often were your 
erections hard enough for penetration?  
0 No sexual stimulation  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never 
Questions 3, 4 and 5 will ask about erections you may have had during sexual intercourse. 
3. Over the past 4 weeks, when you attempted sexual intercourse, how often were you able to 
penetrate (enter) your partner?  
0 Did not attempt intercourse  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never 
4. Over the past 4 weeks, during sexual intercourse, how often were you able to maintain your 
erection after you had penetrated (entered) your partner? 
0 Did not attempt intercourse 
0 Almost always or always 
0 Most times (much more than half the time) 
0 Sometimes (about half the time) 
0 A few times (much less than half the time) 
0 Almost never or never 
5. Over the past 4 weeks, during sexual intercourse, how difficult was it to maintain your erection to 
completion of intercourse?  
0 Did not attempt intercourse  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time) 0 A few times (much less than half the time)  
0 Almost never or never 
6. Over the past 4 weeks, how many times have you attempted sexual intercourse?  
0 No attempts  
0 1-2 attempts  
0 3-4 attempts  
0 5-6 attempts  
0 7-10 attempts  
0 11 or more attempts 
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7. Over the past 4 weeks, when you attempted sexual intercourse how often was it satisfactory for 
you?  
0 Did not attempt intercourse  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never 
8. Over the past 4 weeks, how much have you enjoyed sexual intercourse?  
0 No intercourse  
0 Very highly enjoyable  
0 Highly enjoyable  
0 Fairly enjoyable  
0 Not very enjoyable  
0 Not enjoyable 
9. Over the past 4 weeks, when you had sexual stimulation or intercourse how often did you 
ejaculate?  
0 Did not attempt intercourse  
0 Almost always or always  
0 Most times (more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never  
10. Over the past 4 weeks, when you had sexual stimulation or intercourse how often did you have 
the feeling of orgasm or climax (with or without ejaculation)? 
0 No sexual stimulation or intercourse 
0 Almost always or always 
0 Most times (much more than half the time) 
0 Sometimes (about half the time) 
0 A few times (much less than half the time) 
0 Almost never or never 
Questions 11 and 12 ask about sexual desire. Let's define sexual desire as a feeling that may include 
wanting to have a sexual experience (for example, masturbation or intercourse), thinking about having 
sex or feeling frustrated due to a lack of sex. 
11. Over the past 4 weeks, how often have you felt sexual desire?  
0 Almost always or always  
0 Most times (much more than half the time)  
0 Sometimes (about half the time)  
0 A few times (much less than half the time)  
0 Almost never or never 
12. Over the past 4 weeks, how would you rate your level of sexual desire?  
0 Very high  
0 High  
0 Moderate  
0 Low  
0 Very low or none at all 
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13. Over the past 4 weeks, how satisfied have you been with you overall sex life?  
0 Very satisfied  
0 Moderately satisfied  
0 About equally satisfied and dissatisfied  
0 Moderately dissatisfied  
0 Very dissatisfied 
14. Over the past 4 weeks, how satisfied have you been with your sexual relationship with your 
partner? 
0 Very satisfied 
0 Moderately satisfied 
0 About equally satisfied and dissatisfied 
0 Moderately dissatisfied 
0 Very dissatisfied 
15. Over the past 4 weeks, how do you rate your confidence that you can get and keep your 
erection? 
0 Very high 
0 High 
0 Moderate  
0 Low  
0 Very low 
 
Scoring Algorithm for IIEF 
All items are scored in 5 domains as follows: 
Domain Items Range 
Score Max 
Score 
Erectile Function  1, 2, 3, 4, 5, 15   0-5 30 
Orgasmic Function 9, 10  0-5 10 
Sexual Desire  11, 12  0-5 10 
Intercourse Satisfaction 6, 7, 8  0-5 15 
Overall Satisfaction 13, 14  0-5 10 
Clinical Interpretation 
I. Erectile function total scores can be interpreted as follows: 
Score Interpretation 
0-6 Severe dysfunction 
    
7-12 Moderate dysfunction 
    
13-18 
Mild to moderate 
dysfunction 
    
19-24 Mild dysfunction 
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25-30  No dysfunction 
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PHQ-9 Depression 
 
 
  Over the last 2 weeks, how often have you  
  been bothered by any of the following problems? 
    (Use “✔” to indicate your answer” 
 
  
 
Not at 
all 
 
 
 
Several 
days 
 
More 
than half 
the days 
 
 
Nearly       
every 
 day 
1.  Little interest or pleasure in doing things.......……… 0 1 2 3 
2.  Feeling down, depressed, or hopeless.………..…… 0 1 2 3 
3.  Trouble falling or staying asleep, or sleeping too 
much..................................................………..…….. 
 
  0 
 
1 
 
  2 
 
  3 
4.  Feeling tired or having little energy......……...……… 0 1 2 3 
5.  Poor appetite or overeating.......................……….…     0 1 2 3 
6.  Feeling bad about yourself — or that you are a failure   or 
have let yourself or your family down………………….. 
 
  0 
 
1 
 
2 
 
  3 
7.  Trouble concentrating on things, such as reading the 
newspaper or watching television.……………………….. 
 
  0 
 
1 
 
2 
 
  3 
8.  Moving or speaking so slowly that other people could have 
noticed?  Or the opposite — being so fidgety or restless that you 
have been moving .around a lot more than 
usual..............……………………………………………….. 
 
 
 
 0 
 
 
 
1 
 
 
 
2 
 
 
 
 3 
9.  Thoughts that you would be better off dead or of hurting 
yourself in some way......…………………………………… 
 
 0 
 
1 
 
2 
 
 3 
 
                                                               Column totals          ___     +   ___  + ____  +   ___  
 
                                                                                                 
                                                                                                         =   Total Score _____   
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From the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD PHQ). The PHQ was 
developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues. For research information, contact 
Dr. Spitzer at rls8@columbia.edu. PRIME-MD® is a trademark of Pfizer Inc. Copyright© 1999 Pfizer Inc. All rights reserved. 
Reproduced with permission 
Scoring notes. 
 
 
 PHQ-9 Depression Severity 
 
 
Scores represent: 0-5 = mild    6-10 = moderate    11-15 = moderately severe      
16-20 = severe depression 
 
 
 GAD-7 Anxiety Severity.   
 
This is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of “not at all,” “several 
days,” “more than half the days,” and “nearly every day,” respectively.  GAD-7 total score for the seven 
items ranges from 0 to 21.   
 
Scores represent: 0-5 mild   6-10 moderate   11-15 moderately severe anxiety  
15-21  severe anxiety. 
 
 
 Core-10  
 
Key points in the scoring of the CORE-10 are as follows:  
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1. Each item within the CORE-10 is scored on a 5-point scale ranging from 0 (‘not at all’) 
to 4 (‘most or all the time’).  
 
2. The clinical score is calculated by adding the response values of all 10 items.  
 
3. Where there are missing data the clinical score is derived by calculating the total 
mean score (dividing the total score by the number of completed items) and 
multiplying by 10.  
 
4. We do not recommend re-scaling the clinical score if more than one item is missing.  
 
5. The minimum score that can be achieved is 0 and the maximum is 40.  
 
6. The measure is problem scored, that is, the higher the score the more problems the 
individual is reporting and/or the more distressed they are.  
 
A score of 10 or below denotes a score within the non-clinical range and of 11 
or above within the clinical range. Within the non-clinical range we have identified 
two bands called ‘healthy’ and ‘low’ level distress. People may score on a number of 
items at any particular time but still remain ‘healthy’. Similarly, people may score in the 
‘low’ range which might be a result of raised pressures or particular circumstances but 
which is still within a non-clinical range. Within the clinical range we have identified 
the score of 11 as the lower boundary of the ‘mild’ level, 15 for the ‘moderate’ 
level, and 20 for the ‘moderate-to-severe’ level. A score of 25 or over marks the 
‘severe’ level.  
 
 
